On last quarters sales, we get an annual revenue run rate of $1.25Billion for Illucix alone, and still taking market share. Enter Gozellix, a myriad of products in the pipeline, and global jurisdictional expansion and sky is the limit. Share price would be easy over $40 if not for Trump reference pricing proposals and associated uncertainty. My opinions only.
Ann: Telix Reports US$204M Q2 Revenue, Up 63% YOY, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$20.69 |
Change
0.150(0.73%) |
Mkt cap ! $7.023B | |||
| Open | High | Low | Value | Volume |
| $20.54 | $21.06 | $20.41 | $34.29M | 1.655M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 280 | $20.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.70 | 3537 | 22 |
View Market Depth
| Last trade - 15.37pm 30/07/2025 (20 minute delay) ? |
| TLX (ASX) Chart |